Latest profit margin for Advaxis: -369784.62% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2023
Trailing 12 months ending Dec 2023
The latest profit margin for ADXS is -369784.62% as of December 2023. That compares with -3674.49% in the prior-year period — down 9963.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Advaxis's historical trend and sector peers before judging valuation or financial health.
Over the past year, ADXS's profit margin moved from -3674.49% to -369784.62% — a 9963.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Advaxis's valuation or profitability profile.
Against Healthcare companies, ADXS currently prints -369784.62% for profit margin, while the sector average sits near 13.89%. That is roughly 2662305.7% below the sector mean. Large gaps often invite a closer look at Advaxis's growth, margins, and balance sheet.
Profit Margin shows how effectively Advaxis converts resources into returns. At -369784.62%, ADXS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3674.49% in the prior-year period — down 9963.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ADXS's profit margin (-369784.62%), review year-over-year change from -3674.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.